Please assess the completion status of the following clinical trial:

Trial Title: Spectroscopy Versus Standard Care in Cervical Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years and older~* Non-pregnant~* Patients with abnormal smears with cervical intraepithelial neoplasia (both low grade squamous intraepithelial lesions and high grade squamous intraepithelial lesions equal to cervical intraepithelial neoplasia 1-3)~Exclusion Criteria:~* Patients who have had cytotoxic chemotherapy within 12-months prior to enrolling in this study, since the chemotherapy often induces change in the cervix.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Colposcopy (Type: EXPERIMENTAL): Colposcopy - a direct magnified inspection of cervix
- Colposcopy + Fluorescence Spectroscopy (Type: EXPERIMENTAL): Colposcopy - a direct magnified inspection of cervix + Fluorescence Spectroscopy - electromagnetic spectroscopy which analyzes fluorescence from a sample.
- Colposcopy + LEEP Procedure (Type: EXPERIMENTAL): Colposcopy - a direct magnified inspection of cervix + loop electrosurgical excision procedure (LEEP) - thin, low-voltage electrified wire loop to cuts out cervix abnormal tissue.

Based on this trial design, predict the completion outcome and termination type (if applicable).